# A Clinical Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of SRT501 in Subjects With Colorectal Cancer and Hepatic Metastases

> **NCT00920803** · PHASE1 · COMPLETED · sponsor: **Sirtris, a GSK Company** · enrollment: 9 (actual)

## Conditions studied

- Neoplasms, Colorectal

## Interventions

- **DRUG:** Placebo
- **DRUG:** SRT501

## Key facts

- **NCT ID:** NCT00920803
- **Lead sponsor:** Sirtris, a GSK Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08-19
- **Primary completion:** 2009-11-11
- **Final completion:** 2009-11-11
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2017-06-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00920803

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00920803, "A Clinical Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of SRT501 in Subjects With Colorectal Cancer and Hepatic Metastases". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00920803. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*